Year archive

CELADON PHARMACEUTICALS PLC — 2024 filings

All 22 regulatory filings released by CELADON PHARMACEUTICALS PLC (CEL) in 2024, sourced directly from the official regulator.

22 Filings

2024 Period

2024 filings (22)

Filing	Released	Lang
Finance Update Capital/Financing Update	2024-12-20	English
Receipt of Subscription Proceeds Share Issue/Capital Change	2024-12-06	English
Update on Financial Position Capital/Financing Update	2024-11-18	English
Investor Site Visit – Tuesday 22 October 2024 Regulatory Filings	2024-10-04	English
New Sales Contract with a Healthcare Company Regulatory Filings	2024-10-02	English
Departure of Chief Financial Officer Board/Management Information	2024-09-30	English
Interim Results Earnings Release H1 2024	2024-09-30	English
Admission of Shares and Total Voting Rights Share Issue/Capital Change	2024-09-17	English
Equity Fundraise and Update on Financial Position Share Issue/Capital Change	2024-09-11	English
Strategic collaboration with Valeos Regulatory Filings	2024-09-11	English
Update on Financial Position Share Issue/Capital Change	2024-08-23	English
Update on Operations and Financial Position Capital/Financing Update	2024-08-12	English
Successful Completion of Eighth Harvest of 2024 Regulatory Filings	2024-07-16	English
Third Admission of Shares Share Issue/Capital Change	2024-07-15	English
Result of AGM AGM Information	2024-06-28	English
Second Admission of Shares Share Issue/Capital Change	2024-06-07	English
Publication of Annual Report & Notice of AGM Report Publication Announcement	2024-06-03	English
Supply of Products to New US Customer Earnings Release H2 2024	2024-05-23	English
Exercise of Share Options and Total Voting Rights Regulatory Filings	2024-05-15	English
Final Results Annual Report FY 2023	2024-05-14	English
Fundraise, RCF Extension, Termination of CLN & TVR Share Issue/Capital Change	2024-05-10	English
Early Economic Analysis of Feasibility Study Data Regulatory Filings	2024-03-07	English